Home » Topics » BioWorld Science

BioWorld Science
RSS

Novo Nordisk initiates phase I study of NNC0385-0434 for hypercholesterolemia

Aug. 29, 2019

Phase III results for V-212 inactivated varicella zoster virus vaccine in patients with malignancies

Aug. 29, 2019

For proinflammatory antibody, too much of a bad thing is a good thing

Aug. 29, 2019

Metastasizing cells create their own hypoxia

Aug. 29, 2019

European Commission approves Soliris for neuromyelitis optica spectrum disorder

Aug. 28, 2019

FDA approves Nourianz for Parkinson's disease

Aug. 28, 2019

Genisphere collaborates with University Hospitals in pancreatic cancer

Aug. 28, 2019

Kintai Therapeutics announces academic collaborations in cancer

Aug. 28, 2019

IRLAB to prioritize L-dopa-induced dyskinesia indication in development of IRL-790

Aug. 28, 2019

Bristol-Myers Squibb presents discovery of lupus candidate BMS-615

Aug. 28, 2019

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...